ORIGINAL ARTICLE
Expression of fascin in association with p16 and Ki-67 in cervical lesions: immunohistochemical study
1
Department of Histology and Embryology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01 Martin, Slovakia
2
Department of Anatomy, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01 Martin, Slovakia
3
Department of Pathology, St. Elizabeth Cancer Institute Hospital in Bratislava, 812 50 Bratislava, Slovakia
Submission date: 2022-05-18
Final revision date: 2022-09-05
Acceptance date: 2022-10-15
Publication date: 2023-01-10
Pol J Pathol 2022;73(3):208-214
KEYWORDS
TOPICS
ABSTRACT
Annual gynecological examination with cervical cancer screening and HPV vaccination ensures the appropriate prevention of the onset and progression of cervical cancer. Currently, efforts are being made to find new diagnostic and prognostic biomarkers. Fascin, an actin-bundling protein, promotes cellular migration. Its overexpression has been observed in many types of squamous carcinomas and was usually correlated with a worse prognosis and metastasis. However, the data on fascin expression in cervical lesions are limited.
This study focuses on the quantitative evaluation of fascin expression, the immunoreaction intensity and subcellular localization of fascin expression in low-grade squamous intraepithelial lesions (LSIL), high-grade squamous intraepithelial lesions (HSIL) and squamous cell carcinomas (SCC). Fascin expression was also correlated with the routinely used diagnostic markers p16 and Ki-67. Biopsy specimens (n = 67) of LSIL, HSIL and SCC were taken from adult women in the age range 20–86 years.
Fascin expression was detected by immunohistochemical analysis and quantified using morphometric software. Analysis of variance confirmed statistically significant differences in the percentage of fascin-positive cells between the LSIL, HSIL and SCC groups. Finally, the results showed a significant positive correlation between fascin expression and p16 and Ki-67 expression.
This study focuses on the quantitative evaluation of fascin expression, the immunoreaction intensity and subcellular localization of fascin expression in low-grade squamous intraepithelial lesions (LSIL), high-grade squamous intraepithelial lesions (HSIL) and squamous cell carcinomas (SCC). Fascin expression was also correlated with the routinely used diagnostic markers p16 and Ki-67. Biopsy specimens (n = 67) of LSIL, HSIL and SCC were taken from adult women in the age range 20–86 years.
Fascin expression was detected by immunohistochemical analysis and quantified using morphometric software. Analysis of variance confirmed statistically significant differences in the percentage of fascin-positive cells between the LSIL, HSIL and SCC groups. Finally, the results showed a significant positive correlation between fascin expression and p16 and Ki-67 expression.
REFERENCES (40)
1.
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-249.
2.
Zhang S, Xu H, Zhang L, et al. Cervical cancer: epidemiology, risk factors and screening. Chin J Cancer Res 2020; 32: 720-728.
3.
Lee MY, Shen MR. Epithelial-mesenchymal transition in cervical carcinoma. Am J Transl Res 2012; 4: 1-13.
4.
Zhou S, Wang X, Ding J, et al. Increased ATG5 expression predicts poor prognosis and promotes emt in cervical carcinoma. Front Cell Dev Biol 2021; 9: 75184.
5.
Cao Y, Han Q, Li J, et al. P4HA2 contributes to cervical cancer progression via inducing epithelial-mesenchymal transition. J Cancer 2020; 11: 2788-2799.
6.
Jing L, Wang B, Yourong F, et al. Sema4C mediates EMT inducing chemotherapeutic resistance of miR-31-3p in cervical cancer cells. Sce Rep 2019; 9: 17727.
7.
Campo L, Zhang C, Breuer E K. EMT – inducing molecular factors in gynecological cancers. BioMed Res Int 2015; 2015: e420891.
8.
Qureshi R, Arora H, Rizvi MA. EMT in cervical cancer: its role in tumor progression and response to therapy. J Canc Let 2015; 356: 321-331.
9.
Bryan J, Edwards R, Matsudaira P, et al. Fascin, an echinoid actin-bundling protein, is a homolog of the Drosophila singed gene product. Proc Natl Acad Sci U S A 1993; 90: 9115-9119.
10.
Gupta I, Vranic S, Al-Thawadi H, et al. Fascin in gynecological cancers: an update of the literature. Cancers (Basel) 2021; 13: 5760.
11.
Machesky LM, Li A. Fascin: invasive filopodia promoting metastasis. Commun Integr Biol 2010; 3: 263-270.
12.
Zhang FR, Tao LH, Shen ZY, et al. Fascin expression in human embryonic, fetal, and normal adult tissue. J Histochem Cytochem 2008; 56: 193-199.
13.
Elkhatib N, Neu MB, Zensen C, et al. Fascin plays a role in stress fiber organization and focal adhesion disassembly. Curr Biol 2014; 24: 1492-1499.
14.
Tampakis A, Tampaki EC, Nonni A, et al. High fascin-1 expression in colorectal cancer identifies patients at high risk for early disease recurrence and associated mortality. BMC Cancer 2021; 21: 153.
15.
Lee HJ, An HJ, Kim TH, et al. Fascin expression is inversely correlated with breast cancer metastasis suppressor 1 and predicts a worse survival outcome in node-negative breast cancer patients. J Cancer 2017; 8: 3122-3129.
16.
Papaspyrou K, Brochhausen C, Schmidtmann I, et al. Fascin upregulation in primary head and neck squamous cell carcinoma is associated with lymphatic metastasis. Oncol Lett 2014; 7: 2041-2046.
17.
Hashimoto Y, Shimada Y, Kawamura J, et al. The prognostic relevance of fascin expression in human gastric carcinoma. Oncology 2004; 67: 262-270.
18.
Maitra A, Iacobuzio-Donahue C, Rahman A, et al. Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47. Am J Clin Pathol 2002; 118: 52-59.
19.
Hu W, McCrea PD, Deavers M, et al. Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors. Clin Exp Metastasis 2000; 18: 83-88.
20.
Tan VY, Lewis SJ, Adams JC, et al. Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysis. BMC Med 2013; 11: 52.
21.
Kalluri R, Weinberg AR. The basics of epithelial-mesenchymal transition. J Clin Invest 2010; 120: 1786.
22.
Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal 2014; 7: re8.
23.
Mao X, Duan X, Jiang B. Fascin induces epithelial-mesenchymal transition of cholangiocarcinoma cells by regulating Wnt/-catenin signaling. Med Sci Monit 2016; 22: 3479-3485.
24.
Liu H, Zhang Y, Li L, et al. Fascin actin-bundling protein 1 in human cancer: promising biomarker or therapeutic target? Mol Ther Oncolytics 2021; 20: 240-264.
25.
Beghein E, Devriese D, Van Hoey E, et al. Cortactin and fascin-1 regulate extracellular vesicle release by controlling endosomal trafficking or invadopodia formation and function. Sci Rep 2018; 8: 15606.
26.
Jayo A, Malboubi M, Antoku S, et al. Fascin regulates nuclear movement and deformation in migrating cells. Developmental Cell 2016; 38: 371-383.
27.
Adams JC. Roles of fascin in cell adhesion and motility. Curr Opin Cell Biol 2004; 16: 590-596.
28.
Ma Y, Machesky LM. Fascin1 in carcinomas: its regulation and prognostic value. Int J Cancer 2015; 137: 2534-2544.
29.
Ghalejoogh ZY, Samani SM, Malekshahi SS, et al. Human papilloma virus infection and fascin over-expression in squamous cell carcinoma of the cervix. Med J Islam Repub Iran 2018; 32: 134.
30.
Koay MHE, Crook M, Stewart CJR. Fascin expression in cervical normal squamous epithelium, cervical intraepithelial neoplasia, and superficially invasive (stage IA1) squamous carcinoma of the cervix. Pathology 2014; 46: 433-438.
31.
Kabukcuoglu S, Ozalp SS, Oner U, et al. Fascin, an actin-bundling protein expression in cervical neoplasms. Eur J Gynaecol Oncol 2005; 26: 636-641.
32.
Heinz LS, Muhs S, Schiewek J, et al. Strong fascin expression promotes metastasis independent of its F-actin bundling activity. Oncotarget 2017; 8: 110077-110091.
33.
Lamb MC, Tootle TL. Fascin in cell migration: more than an actin bundling protein. Biology (Basel) 2020; 9: E403.
34.
Groen CM, Jayo A, Parsons M, et al. Prostaglandins regulate nuclear localization of Fascin and its function in nucleolar architecture. Mol Biol Cell 2015; 26: 1901-1917.
35.
Saad A, Krikor B, Dinghong Q, et al. Insights into a novel nuclear function for Fascin in the regulation of the amino-acid transporter SLC3A2. Sci Rep 2016; 6: 36699.
36.
Hebbar A, Murthy VS. Role of p16/INK4a and Ki-67 as specific biomarkers for cervical intraepithelial neoplasia: an institutional study. J Lab Physicians 2017; 9: 104-110.
37.
Leite PM de O, Tafuri L, Costa MZ de O, et al. Evaluation of the p16 and Ki-67 biomarkers as predictors of the recurrence of premalignant cervical cancer lesions after LEEP conization. Rev Bras Ginecol Obstet 2017; 39: 288-293.
38.
De Melo FLP, Lancellotti CLP, da Silva MALG. Expression of the immunohistochemical markers p16 and Ki-67 and their usefulness in the diagnosis of cervical intraepithelial neoplasms. Rev Bras Ginecol Obstet 2016; 38: 82-87.
39.
Li LT, Jiang G, Chen Q, et al. Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol Med Rep 2015; 11: 1566-1572.
40.
Abosarie MA, Ibrahim HA. Immunohistochemical study on Fascin-1 and Ki-67 as potentially poor prognostic marker in prostatic carcinoma. Egypt J Pathol 2019; 39: 108-114.
Share
RELATED ARTICLE
| eISSN: | 2084-9869 |
| ISSN: | 1233-9687 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
